TY  - GEN
AU  - Pantuck,Allan J
AU  - van Ophoven,Arndt
AU  - Gitlitz,Barbara J
AU  - Tso,Cho-Lea
AU  - Acres,Bruce
AU  - Squiban,Patrick
AU  - Ross,Michael E
AU  - Belldegrun,Arie S
AU  - Figlin,Robert A
TI  - Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer
SN  - 1524-9557
PY  - 2004///1221
KW  - Aged
KW  - CD4 Antigens
KW  - biosynthesis
KW  - CD8 Antigens
KW  - Cancer Vaccines
KW  - therapeutic use
KW  - Cell Separation
KW  - Clinical Trials as Topic
KW  - Dose-Response Relationship, Drug
KW  - Flow Cytometry
KW  - Genetic Therapy
KW  - methods
KW  - Genetic Vectors
KW  - Humans
KW  - Immunotherapy
KW  - Interleukin-2
KW  - genetics
KW  - Male
KW  - Middle Aged
KW  - Mucin-1
KW  - Phenotype
KW  - Prostatic Neoplasms
KW  - therapy
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Th1 Cells
KW  - Time Factors
KW  - Tumor Necrosis Factor-alpha
KW  - metabolism
KW  - Up-Regulation
KW  - Vaccinia virus
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00002371-200405000-00009
ER  -